Cargando…
Evaluation of Whole-Genome Sequencing for Mycobacterial Species Identification and Drug Susceptibility Testing in a Clinical Setting: a Large-Scale Prospective Assessment of Performance against Line Probe Assays and Phenotyping
Use of whole-genome sequencing (WGS) for routine mycobacterial species identification and drug susceptibility testing (DST) is becoming a reality. We compared the performances of WGS and standard laboratory workflows prospectively, by parallel processing at a major mycobacterial reference service ov...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786738/ https://www.ncbi.nlm.nih.gov/pubmed/29167290 http://dx.doi.org/10.1128/JCM.01480-17 |
_version_ | 1783295823289778176 |
---|---|
author | Quan, T. Phuong Bawa, Zharain Foster, Dona Walker, Tim del Ojo Elias, Carlos Rathod, Priti Iqbal, Zamin Bradley, Phelim Mowbray, Janet Walker, A. Sarah Crook, Derrick W. Wyllie, David H. Peto, Timothy E. A. Smith, E. Grace |
author_facet | Quan, T. Phuong Bawa, Zharain Foster, Dona Walker, Tim del Ojo Elias, Carlos Rathod, Priti Iqbal, Zamin Bradley, Phelim Mowbray, Janet Walker, A. Sarah Crook, Derrick W. Wyllie, David H. Peto, Timothy E. A. Smith, E. Grace |
author_sort | Quan, T. Phuong |
collection | PubMed |
description | Use of whole-genome sequencing (WGS) for routine mycobacterial species identification and drug susceptibility testing (DST) is becoming a reality. We compared the performances of WGS and standard laboratory workflows prospectively, by parallel processing at a major mycobacterial reference service over the course of 1 year, for species identification, first-line Mycobacterium tuberculosis resistance prediction, and turnaround time. Among 2,039 isolates with line probe assay results for species identification, 74 (3.6%) failed sequencing or WGS species identification. Excluding these isolates, clinically important species were identified for 1,902 isolates, of which 1,825 (96.0%) were identified as the same species by WGS and the line probe assay. A total of 2,157 line probe test results for detection of resistance to the first-line drugs isoniazid and rifampin were available for 728 M. tuberculosis complex isolates. Excluding 216 (10.0%) cases where there were insufficient sequencing data for WGS to make a prediction, overall concordance was 99.3% (95% confidence interval [CI], 98.9 to 99.6%), sensitivity was 97.6% (91.7 to 99.7%), and specificity was 99.5% (99.0 to 99.7%). A total of 2,982 phenotypic DST results were available for 777 M. tuberculosis complex isolates. Of these, 356 (11.9%) had no WGS comparator due to insufficient sequencing data, and in 154 (5.2%) cases the WGS prediction was indeterminate due to discovery of novel, previously uncharacterized mutations. Excluding these data, overall concordance was 99.2% (98.7 to 99.5%), sensitivity was 94.2% (88.4 to 97.6%), and specificity was 99.4% (99.0 to 99.7%). Median processing times for the routine laboratory tests versus WGS were similar overall, i.e., 20 days (interquartile range [IQR], 15 to 31 days) and 21 days (15 to 29 days), respectively (P = 0.41). In conclusion, WGS predicts species and drug susceptibility with great accuracy, but work is needed to increase the proportion of predictions made. |
format | Online Article Text |
id | pubmed-5786738 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | American Society for Microbiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-57867382018-02-07 Evaluation of Whole-Genome Sequencing for Mycobacterial Species Identification and Drug Susceptibility Testing in a Clinical Setting: a Large-Scale Prospective Assessment of Performance against Line Probe Assays and Phenotyping Quan, T. Phuong Bawa, Zharain Foster, Dona Walker, Tim del Ojo Elias, Carlos Rathod, Priti Iqbal, Zamin Bradley, Phelim Mowbray, Janet Walker, A. Sarah Crook, Derrick W. Wyllie, David H. Peto, Timothy E. A. Smith, E. Grace J Clin Microbiol Mycobacteriology and Aerobic Actinomycetes Use of whole-genome sequencing (WGS) for routine mycobacterial species identification and drug susceptibility testing (DST) is becoming a reality. We compared the performances of WGS and standard laboratory workflows prospectively, by parallel processing at a major mycobacterial reference service over the course of 1 year, for species identification, first-line Mycobacterium tuberculosis resistance prediction, and turnaround time. Among 2,039 isolates with line probe assay results for species identification, 74 (3.6%) failed sequencing or WGS species identification. Excluding these isolates, clinically important species were identified for 1,902 isolates, of which 1,825 (96.0%) were identified as the same species by WGS and the line probe assay. A total of 2,157 line probe test results for detection of resistance to the first-line drugs isoniazid and rifampin were available for 728 M. tuberculosis complex isolates. Excluding 216 (10.0%) cases where there were insufficient sequencing data for WGS to make a prediction, overall concordance was 99.3% (95% confidence interval [CI], 98.9 to 99.6%), sensitivity was 97.6% (91.7 to 99.7%), and specificity was 99.5% (99.0 to 99.7%). A total of 2,982 phenotypic DST results were available for 777 M. tuberculosis complex isolates. Of these, 356 (11.9%) had no WGS comparator due to insufficient sequencing data, and in 154 (5.2%) cases the WGS prediction was indeterminate due to discovery of novel, previously uncharacterized mutations. Excluding these data, overall concordance was 99.2% (98.7 to 99.5%), sensitivity was 94.2% (88.4 to 97.6%), and specificity was 99.4% (99.0 to 99.7%). Median processing times for the routine laboratory tests versus WGS were similar overall, i.e., 20 days (interquartile range [IQR], 15 to 31 days) and 21 days (15 to 29 days), respectively (P = 0.41). In conclusion, WGS predicts species and drug susceptibility with great accuracy, but work is needed to increase the proportion of predictions made. American Society for Microbiology 2018-01-24 /pmc/articles/PMC5786738/ /pubmed/29167290 http://dx.doi.org/10.1128/JCM.01480-17 Text en Copyright © 2018 Quan et al. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Mycobacteriology and Aerobic Actinomycetes Quan, T. Phuong Bawa, Zharain Foster, Dona Walker, Tim del Ojo Elias, Carlos Rathod, Priti Iqbal, Zamin Bradley, Phelim Mowbray, Janet Walker, A. Sarah Crook, Derrick W. Wyllie, David H. Peto, Timothy E. A. Smith, E. Grace Evaluation of Whole-Genome Sequencing for Mycobacterial Species Identification and Drug Susceptibility Testing in a Clinical Setting: a Large-Scale Prospective Assessment of Performance against Line Probe Assays and Phenotyping |
title | Evaluation of Whole-Genome Sequencing for Mycobacterial Species Identification and Drug Susceptibility Testing in a Clinical Setting: a Large-Scale Prospective Assessment of Performance against Line Probe Assays and Phenotyping |
title_full | Evaluation of Whole-Genome Sequencing for Mycobacterial Species Identification and Drug Susceptibility Testing in a Clinical Setting: a Large-Scale Prospective Assessment of Performance against Line Probe Assays and Phenotyping |
title_fullStr | Evaluation of Whole-Genome Sequencing for Mycobacterial Species Identification and Drug Susceptibility Testing in a Clinical Setting: a Large-Scale Prospective Assessment of Performance against Line Probe Assays and Phenotyping |
title_full_unstemmed | Evaluation of Whole-Genome Sequencing for Mycobacterial Species Identification and Drug Susceptibility Testing in a Clinical Setting: a Large-Scale Prospective Assessment of Performance against Line Probe Assays and Phenotyping |
title_short | Evaluation of Whole-Genome Sequencing for Mycobacterial Species Identification and Drug Susceptibility Testing in a Clinical Setting: a Large-Scale Prospective Assessment of Performance against Line Probe Assays and Phenotyping |
title_sort | evaluation of whole-genome sequencing for mycobacterial species identification and drug susceptibility testing in a clinical setting: a large-scale prospective assessment of performance against line probe assays and phenotyping |
topic | Mycobacteriology and Aerobic Actinomycetes |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786738/ https://www.ncbi.nlm.nih.gov/pubmed/29167290 http://dx.doi.org/10.1128/JCM.01480-17 |
work_keys_str_mv | AT quantphuong evaluationofwholegenomesequencingformycobacterialspeciesidentificationanddrugsusceptibilitytestinginaclinicalsettingalargescaleprospectiveassessmentofperformanceagainstlineprobeassaysandphenotyping AT bawazharain evaluationofwholegenomesequencingformycobacterialspeciesidentificationanddrugsusceptibilitytestinginaclinicalsettingalargescaleprospectiveassessmentofperformanceagainstlineprobeassaysandphenotyping AT fosterdona evaluationofwholegenomesequencingformycobacterialspeciesidentificationanddrugsusceptibilitytestinginaclinicalsettingalargescaleprospectiveassessmentofperformanceagainstlineprobeassaysandphenotyping AT walkertim evaluationofwholegenomesequencingformycobacterialspeciesidentificationanddrugsusceptibilitytestinginaclinicalsettingalargescaleprospectiveassessmentofperformanceagainstlineprobeassaysandphenotyping AT delojoeliascarlos evaluationofwholegenomesequencingformycobacterialspeciesidentificationanddrugsusceptibilitytestinginaclinicalsettingalargescaleprospectiveassessmentofperformanceagainstlineprobeassaysandphenotyping AT rathodpriti evaluationofwholegenomesequencingformycobacterialspeciesidentificationanddrugsusceptibilitytestinginaclinicalsettingalargescaleprospectiveassessmentofperformanceagainstlineprobeassaysandphenotyping AT evaluationofwholegenomesequencingformycobacterialspeciesidentificationanddrugsusceptibilitytestinginaclinicalsettingalargescaleprospectiveassessmentofperformanceagainstlineprobeassaysandphenotyping AT iqbalzamin evaluationofwholegenomesequencingformycobacterialspeciesidentificationanddrugsusceptibilitytestinginaclinicalsettingalargescaleprospectiveassessmentofperformanceagainstlineprobeassaysandphenotyping AT bradleyphelim evaluationofwholegenomesequencingformycobacterialspeciesidentificationanddrugsusceptibilitytestinginaclinicalsettingalargescaleprospectiveassessmentofperformanceagainstlineprobeassaysandphenotyping AT mowbrayjanet evaluationofwholegenomesequencingformycobacterialspeciesidentificationanddrugsusceptibilitytestinginaclinicalsettingalargescaleprospectiveassessmentofperformanceagainstlineprobeassaysandphenotyping AT walkerasarah evaluationofwholegenomesequencingformycobacterialspeciesidentificationanddrugsusceptibilitytestinginaclinicalsettingalargescaleprospectiveassessmentofperformanceagainstlineprobeassaysandphenotyping AT crookderrickw evaluationofwholegenomesequencingformycobacterialspeciesidentificationanddrugsusceptibilitytestinginaclinicalsettingalargescaleprospectiveassessmentofperformanceagainstlineprobeassaysandphenotyping AT wylliedavidh evaluationofwholegenomesequencingformycobacterialspeciesidentificationanddrugsusceptibilitytestinginaclinicalsettingalargescaleprospectiveassessmentofperformanceagainstlineprobeassaysandphenotyping AT petotimothyea evaluationofwholegenomesequencingformycobacterialspeciesidentificationanddrugsusceptibilitytestinginaclinicalsettingalargescaleprospectiveassessmentofperformanceagainstlineprobeassaysandphenotyping AT smithegrace evaluationofwholegenomesequencingformycobacterialspeciesidentificationanddrugsusceptibilitytestinginaclinicalsettingalargescaleprospectiveassessmentofperformanceagainstlineprobeassaysandphenotyping |